A complete response letter (CRL) from the FDA delays a product's entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them. Imagine how much you could save if you could anticipate the FDA's concerns and address them before the agency issues the complete response letter? Now you can.
Express Scripts and Medco Health Solutions sought dismissal of an antitrust suit brought by a coalition of trade groups and retail pharmacies seeking to block the companies’ $29.1 billion merger, saying the delay in filing the suit until after the merger was completed is inexcusable. Law360